Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2005
08/11/2005US20050176060 Crystal structure
08/10/2005EP1561751A1 Fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
08/10/2005EP1560828A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands
08/10/2005EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
08/10/2005EP1560816A1 Quinazoline derivatives
08/10/2005EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
08/10/2005EP1507514A4 Controlled release compositions of estradiol metabolites
08/10/2005EP1358187B1 Naphthyridine derivatives
08/10/2005EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors
08/10/2005EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists
08/10/2005EP1301207B1 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin
08/10/2005EP1292581B1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
08/10/2005EP1208103B1 Reverse-turn mimetics and methods relating thereto
08/10/2005EP1042359B1 Kappa receptor opioid peptides
08/10/2005EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
08/10/2005CN1653075A C-aryl glucoside SGLT2 inhibitors and method
08/10/2005CN1653050A Opioid and opioid-like compounds and uses thereof
08/10/2005CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
08/10/2005CN1653044A Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653025A NK1 antagonists
08/10/2005CN1652821A Human monoclonal antibodies to prostate specific membrane antigen (PSMA)
08/10/2005CN1652810A Immunosuppressant compounds, methods and uses related thereto
08/10/2005CN1652787A Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
08/10/2005CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/10/2005CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652777A Combination of organic compounds
08/10/2005CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1652769A Phosphate prodrugs of fluorooxindoles
08/10/2005CN1652761A Preventive or therapeutic agent for kidney disease
08/10/2005CN1652760A Tamsulosin tablets
08/10/2005CN1652758A Methods of treating gastrointestinal and genitourinary pain disorders using vinlafaxin and derivatives
08/10/2005CN1652687A Choline-silicic acid complex with osmolytes and divalent trace elements
08/10/2005CN1651432A Method of refining plamatine from herba fibranreae recisae total ulkuloid and its application
08/10/2005CN1651087A Combination of organic compounds
08/10/2005CN1651074A Use of neurotoxin therapy for treatment of urologic and related disorders
08/10/2005CN1651057A Cinnamon poria capsule and its preparation process
08/10/2005CN1651056A Cinnamon poria capsule and its preparation process
08/10/2005CN1651053A Chinese medicinal preparation for treating glomerulus nephritis
08/10/2005CN1651052A Chinese medicinal preparation for treating pelvis nephritis
08/10/2005CN1651051A Chinese medicinal preparation for treating pelvis nephritis
08/10/2005CN1651050A Chinese medicinal preparation for treating pelvis nephritis
08/10/2005CN1651049A Chinese medicinal preparation for treating pelvis nephritis
08/10/2005CN1651048A Chinese medicinal preparation for treating pelvis nephritis
08/10/2005CN1651047A Chinese medicinal preparation for treating pelvis nephritis
08/10/2005CN1651046A Chinese medicinal preparation for treating kidney disease syndrome
08/10/2005CN1651045A Chinese medicinal preparation for treating kidney disease syndrome
08/10/2005CN1651044A Chinese medicinal preparation for treating kidney disease syndrome
08/10/2005CN1651043A Chinese medicinal preparation for treating nephropathy syndrome
08/10/2005CN1651040A Preparation method of Fuyankang medicine for treating gynecopathy
08/10/2005CN1651025A Hua Tuo kidney fortifying wine and its preparation method
08/10/2005CN1650986A Chinese medicinal preparation for treating glumerulitis
08/10/2005CN1650985A Chinese medicineal preparation for treating glomerulitis
08/10/2005CN1650984A Chinese medicinal preparation for treating glomerulitis
08/10/2005CN1650983A Chinese medicinal preparation for treating nephropyelitis
08/10/2005CN1650982A Chinese medicinal preparation for treating kidney disease symtomgroup
08/10/2005CN1650971A Preparation method of rape myricyl powder effective portion group
08/10/2005CN1650957A Eight corrections effervescent granules and its preparation method
08/10/2005CN1650926A Chinese medicine for treating urinary system calculus
08/10/2005CN1650924A Four component tumeric tablet and its preparation method
08/10/2005CN1650910A Natural product for treating improving and preventing prostatauxe and its manufacturing process
08/10/2005CN1650894A Method of extracting compound male moth hidney fortifying raw material possesing improving sexual living quality from pure Chinese medicinal preparation
08/10/2005CN1214029C 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroi-soquinol-2-yl)-5-(2-pyridyl) quinazo line mesylat and polymorphs
08/10/2005CN1214022C Vitamin D analogues
08/10/2005CN1214017C 四唑衍生物 Tetrazole derivatives
08/10/2005CN1214008C Therapeutic biaryl derivatives
08/10/2005CN1213999C Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
08/10/2005CN1213750C New use of bergenin in treating chronic prostatitis and proliferative diseases
08/10/2005CN1213743C New use of tea polyphenols for treating prostatosis
08/09/2005US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity
08/09/2005US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
08/09/2005US6927224 Anticancer agents; osteoporosis
08/09/2005US6927222 Compounds
08/09/2005US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents
08/09/2005US6926898 Albumin fusion proteins
08/09/2005CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
08/09/2005CA2303217C Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients
08/09/2005CA2249330C Method of treating heart failure with endothelin antagonists
08/04/2005WO2005070923A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
08/04/2005US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders
08/04/2005US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/04/2005US20050171186 3-(1',2'-Dihydro-2'-thioxospiro[cyclohexane-1,3'-[3H]indol]-5'-yl)benzonitrile; 5'-(5-Cyano-1-methyl-1H-pyrrol-2-yl)spiro[cyclohexane-1,3'-[3H]indol]-2'-ylidenecyanamide; progesterone receptor agonist; mixture with estrone (estrogen); hormone replacement therapy, contraception; anticarcinogenic
08/04/2005US20050171174 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/04/2005US20050171129 Polycyclic guanine derivative phosphodiesterase V inhibitors
08/04/2005US20050171123 Quinazoline derivatives as medicaments
08/04/2005US20050171122 Mitotic kinesin inhibitors
08/04/2005US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors
08/04/2005US20050171068 Novel 4-dedimethylaminotetracycline derivatives
08/04/2005US20050171065 NAALADas, N-Acetylated-Alpha-Linked-Acidic-Dipeptidase inhibitors; 5-phosphonomethyl-1,3-benzenedicarboxylic Acid; glutamate abnormalities, anticancer, antidiabetic agent, angiogenesis inhibitor, neuropathy, pain, compulsive disorders, prostate diseases, glaucoma
08/04/2005US20050169913 Administering a monoclonal antibody or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss; inhibiting gene expression of prothrombinase
08/04/2005CA2554234A1 Use of low-dose erythropoietin for stimulating endothelial precursor cells, regenerating organs, and slowing down progression of end organ damages
08/04/2005CA2554047A1 Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
08/03/2005EP1559726A2 Growth differentiation factor-10
08/03/2005EP1559428A1 Receptor regulator
08/03/2005EP1559427A1 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
08/03/2005EP1559422A1 Receptor function controlling agent
08/03/2005EP1559317A1 Nonbacterial prostatitis model animal
08/03/2005EP1558598A1 Triazole compounds for the treatment of dysmenorrhoea
08/03/2005EP1558080A2 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor
1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 562